Journal: Cell Death and Differentiation
Article Title: Gm364 coordinates MIB2/DLL3/Notch2 to regulate female fertility through AKT activation
doi: 10.1038/s41418-021-00861-5
Figure Lengend Snippet: A , G , J , Q To investigate the signal pathway of how Gm364 regulates AKT activation, we created four working models and examined which was the correct pathway. The upstream parts for all four models, i.e., Gm364 binds with MIB2 and DLL3 to promote the cleavage of Notch2 into active NICD2, were the same, while the signals downstream from NICD2 were distinct from each other. A – F Model 1: if NICD2 first activates mTORC2, then mTORC2 activates AKT, we expected that Gm364 knockout would significantly decrease p-RICTOR (a component of mTORC2). However, p-RICTOR was unaltered by Gm364 knockout ( B ) and ( C ), and p-RICTOR did not interact with Gm364 ( D ), Notch2 ( E ), and NICD2 ( F ), suggesting that Model 1 was incorrect. G – I Model 2: If NICD2 entered the nucleus to promote Akt transcription, we expected that Gm364 knockout would significantly decrease Akt mRNA levels. However, Akt mRNA was unaltered, suggesting that Model 2 was also incorrect. J – P Model 3: if NICD2 entered the nucleus to inhibit Pten transcription, whereas PTEN negatively regulated AKT, we expected that Gm364 knockout would significantly increase PTEN protein and mRNA levels. However, neither PTEN protein ( K ) and ( L ) nor mRNA level ( M ) and ( N ) was altered, and neither NICD2 ( O ) nor Gm364 ( P ) interact with PTEN, suggesting that Model 3 was also incorrect. Q – U Model 4: if NICD2 could directly activate (phosphorylate) AKT, we expected that Gm364 knockout would significantly decrease p-AKT. Here, Gm364 knockout significantly reduced AKT phosphorylation at both S473 and T308 ( R ) and ( S ), and both NICD2 ( T ) and Gm364 interact with AKT ( U ), suggesting that Model 4 was correct. GAPDH was used as a loading control.
Article Snippet: Primary antibodies: Mouse monoclonal anti-GAPDH (Cat#: 30201ES60; YEASEN, Shanghai, China); mouse monoclonal anti-β-Actin (Cat#: A5316-100; Sigma, MS, USA); Mouse monoclonal anti-β-Tubulin (Cat#: sc-5274; Santa Cruz, TX, USA); Mouse monoclonal anti‐alpha Tubulin (Acetyl Lys40) (cat#:bsm‐33235M; Bioss, Beijing, China); Human anti-centromere CREST antibody (cat#: 15-234; Antibodies Incorporated, USA); rabbit polyclonal anti-Notch2 (cat#: ab8926, Abcam, Cambridge, UK); Rabbit polyclonal anti-cleaved Notch2 (Asp 1733) antibody (cat#:AF5255; Affinity biosciences, OH, USA); Anti-DLL3 rabbit polyclonal antibody (cat#: Ab103102; Abcam, Cambridge, UK); Anti-MIB2 rabbit polyclonal antibody (cat#: A17829; ABclonal, MA, USA); anti-Phosphorylation RICTOR (Thr1135) (cat#: D30A3, Cell Signaling Technology, MA, USA); Anti-AKT (Ab-129) Rabbit polyclonal antibody (Cat#: D151616-0100; BBI Life science, Shanghai, China); Rabbit anti-Phospho AKT (Thr308, Cat#: 13038, Cell Signaling Technology); Rabbit anti-Phosphpho AKT (Ser473, Cat# 4060, Cell Signaling Technology); Mouse monoclonal anti-strep II Tag (Cat#: YFMA0054, Yifeixue, Nanjing, China); mouse monoclonal anti-flag Tag (Cat#: D190828, BBI Life science).
Techniques: Activation Assay, Knock-Out